Meningitis por Neisseria meningitidis no tipificable. Reporte de un caso y revisión de la literatura.
Contenido principal del artículo
Resumen
La meningitis por Neisseria meningitidis (N. meningitidis) o meningococo es poco común en México, los casos son esporádicos, los serogrupos B y C son los más frecuentes. La tipificación en algunos casos es difícil de realizar. Los mecanismos de patogenicidad, los factores del hospedero que influyen en la presentación clínica, en el pronóstico y la respuesta al tratamiento son analizados en esta revisión que presentamos a propósito de un caso clínico esporádico, tratado satisfactoriamente en el Hospital Central Militar, en el que se identificó N. meningitidis no tipificable.
Detalles del artículo
Sección
Cómo citar
Referencias
Peter JB. Use and interpretation of tests in medical microbiology. Third Ed. Sta. Monica. CA USA: Seciality Lab Inc; 1992-93; 163-65.
Jawetz E, Melnick JL, Adelberg EA. Manual de Microbiología Médica. 9a. Ed. México: Manual Moderno; l981; 195-7.
Frasch CE, Zollinger WD, Poolman JT. Serotype antigens of Neisseria meningitidis and a proposed scheme for designation of serotypes. Rev Infect Dis 1985; 7: 504-10.
Williams RG, Hart CA. Rapid identification of bacterial antigens in blood cultures and cerebrospinal fluid. J Clin Pathol 1988; 41: 691-3.
Peltola H. Meningococcal disease: Still with us. Rev Infect Dis 1985;7: 504-10.
Sippel JE. Meningococci. Crit Rev Microbiol 1981; 8: 267-302.
CDC. Surveillance for diabetes mellitus. United States, 1980-1989, and laboratory based surveillance for meningococcal disease in selected areas. United States. 1989-1991. MMWR 1993; 42(No. SS-2): 21-30.
Caugant DA. Population genetics and molecular epidemiology of Neisseria meningitidis. APMIS 1998; 106: 505-25.
Kwara A, Adegbola RA, Corrah PT, Weber M, Achtman M, Morrelli G. Meningitis caused by a serogroup W135 clone of the ET-37 complex of Neisseria meningitidis in West Africa. Trop Med Int Health 1998; 3: 742-6.
Feavers MI, Fox AJ, Gray S, Jones DM, Maiden MC. Antigenic diversity of meningococcal outer membrane protein PorA has implications for epidemiological analysis and vaccine design. Clin Diagn Lab Immonol 1996; 3: 444-50.
Dworzack DL, Sanders CC, Horowitz EA y col. Evaluation of single dose ciprofloxacin in the erradication of Neisseria meningitidis from nasopharyngeal carriers. Antimicrob Agents Chemother 1988; 32: 1741-1741.
Judson FN, Ehret JM. Single dose ceftriaxone to eradicate pharyngeal Neisseria meningitidis. Lancet 1984; 2: 1462-3.
CDC. Meningococcal vaccines. MMWR 1985; 34: 255-9.
CDC. Control and prevention of meningococcal disease and control and prevention of serogroup C meningococcal disease: Evaluation and management of suspected outbreaks: Recommendations of Advisory Committee on Immunization Practices (ACIP). MMWR 1997; 46(No. RR-5).
Riedo FX, Plikaytis BD, Broomed CV. Epidemiology and prevention of meningococcal disease. Pediatr Infect Dis J 1995; 14: 643-57.
Booy R, Kroll JS. Bacterial meningitis and meningococcal infection. Curr Opin Pediatr 1998; 10: 13-18.
Zhu ZB, Totemchokchyakarn K, Atkinson TP, Volanakis JE. Molecular defects leading to human complement component C6 deficiency in an African American family. Clin Exp Immunol 1998; 111: 91-6.
Densen P, Weiler JM, Griffiss JM, Hoffmann LG. Familial properdin deficiency and fatal meningococcemia. N Engl J Med 1987; 316: 922-6.
Westendorp RG, Langermans JA, Huizinga TW, Elouali AH, Verweij CL, Boomsma DI. Genetic influence on cytokine production and fatal meningococcal disease. Lancet 1997; 349: 170-3.
Gironell A, Domingo P, Mancebo J, Coll P, Marti-Vilalta JL. Hemorrhagic stroke as a complication of bacterial meningitis in adults: Report of three cases and review. Clin Infect Dis 1995; 21: 1488-91.
Zurita J, Naranjo A, Ontaneda S, Quinones E. Meningitis bacteriana en la infancia: Una revisión de 357 casos en un periodo de seis años en Quito. Enferm Infecc y Microbiol (Mex) 1995; 15: 121-5.
Castañeda JL, Rodríguez E, González SN. Nuevos conceptos en meningitis bacteriana. Rev Mex Pediatr 1990; 3: 131-8.
Echevarría JL, Origel A, Gutiérrez L. Meningitis purulenta en el neonato: I Diagnóstico y bacteriología. Bol Med Hosp Infant Mex 1981; 6: 933-9.
Gutiérrez TJ, Sosa E, Pérez A. Agentes etiológicos bacterianos en casos de meningitis pediátrica en dos hospitales de la ciudad de Puebla, México. Rev Latinoamer Microbiol 1990; 32: 89-94.
Sistema Único de Información para la Vigilancia Epidemiológica. Información preliminar. DGE. Página de Internet de la Secretaría de Salud. Casos nuevos de enfermedades de notificación inmediata hasta la semana 45 de 1998.
CDC. Case definitions for infectious conditions under public health surveillance. MMWR 1997; 46(RR-10): 24.
Cunniffe JG, Whitby SS, Wilcox MH. Effect of pH changes in cerebrospinal fluid specimens on bacterial survival and antigen test results. J Clin Pathol 1996; 49: 249-53.
CDC. Serogroup Y meningococcal disease. US 1989-1996. MMWR 1996; 45: 1010-3.
CDC. National Electronic Telecommunications System for Surveillance. United States, 1990-1991. MMWR 1991; 40: 502-3.
Stephens DS, Hajjeh RA, Baughman WS, Harvey RC, Wenger JD, Farley MM. Sporadic meningococcal disease in adults: Results of a 5 year population-based study. Ann Intern Med 1995; 123: 937-40.
Sigurdatdóttir B, Már BO, Jónsdóttir KE, Erlendsdóttir H, Gudmundosson S. Acute bacterial meningitis in adults. Arch Intern Med 1997; 157: 425-30.
Van der Ende A, Schuurman IG, Hopman CT, Fijer CA, Dankert J. Comparison of commercial diagnostic test for identification of serogroup antigens of Neisseria meningitidis. J Clin Microbiol 1995; 33: 3326- 3326.
Milhaud D, Bernardin G, Rastello M, Mattei M, Blard JM. Bacterial meningitis in adults in the intensive care unit. Clinical analysis and study of prognostic factors. Presse Med 1996; 25: 353-9.
Hosoglu S, Ayaz C, Geyik MF, Kokoglu OF, Ozen A. Acute bacterial meningitis in adults: Analysis of 218 episodes. Ir J Med Sci 1997; 166: 231-4.
Schuchat A, Robinson K, Wenger JD, Harrison LH, Farley M, Reingold AL. Bacterial meningitis in the United States in 1995. N Engl J Med 1997; 337: 970-6.
Flaegstad T, Kaaresen PI, Stokiand T, Gutteberg T. Factors associated with fatal outcome in childhood meningococcal disease. Acta Paediatr 1995; 84: 1137-42.
Juncal AR, Pérez del Molino ML, Rodríguez I, Cid A, Guillan B, Pardo F. Clinical and epidemiologic study of meningococcal meningitis in the health region of Santiago de Compostela (1990-1997). Enferm Infecc Microbiol Clin 1997; 15: 510-4.
Durand ML, Calderwood SB, Weber DJ y col. Acute bacterial meningitis in adults: A review of 493 episodes. N Engl J Med 1993; 328: 21-8.
Pfister HW, Feiden W, Einhaupl KM: Spectrum of complications during bacterial meningitis in adults: Results of clinical study. Arch Neurol 1993; 50: 575-81.
Tunkel AR, Wispelway B, Scheld WM. Bacterial meningitis: Recent advances in pathophysiology and treatment. Ann Intern Med 1990; 112: 610-23.
Babich EM. The phenotypic heterogeneity of meningococcal strains by their serogroup trait. Mikrobiol Z (Russian) 1996; 58: 65-72.
Tinsley CR, Nassif X. Analysis of genetic differences between Neisseria meningitiditis and Neisseria gonorrhoeae: Two closely related bacteria expressing two different pathogenicities. Proc Natl Acad Sci USA 1996; 93: 11109-14.
Charlton R. Meningococcal disease. Is early diagnosis possible? Aust Fam Physician 1998; 27: 495-7.
Galimand M, Gerbaud G, Guibourdenche M, Riou JY, Courvalin P. High level chloramphenicol resistance in Neisseria meningitidis. N Engl J Med 1998; 339: 868-74.
Vogel U, Morelli G, Zurth K, Clauss H, Kriener E, Achtman M. Necessity of molecular techniques to distinguish between Neisseria meningitidis strains isolated from patients with meningococcal disease and from their healthy contacts. J Clin Microbiol 1998; 36: 2465-7.
Kotilainen P, Jalava J, Meurman O, Lehtonen OP, Rintala E, Seppala OP. Diagnosis of meningococcal meningitis by broad range bacterial PCR with cerebrospinal fluid. J Clin Microbiol 1998; 36: 2205-9.
Seaz NJA, Vázquez JA. Moderate resistance to penicillin in Neisseria meningitidis. Microbiología 1997; 13: 337-42.
Anónimo. Annual report of the Australian meningococcal surveillance programme 1996. Commun Dis Intell 1997; 21: 217-221.
Martin DR, Walker SJ, Baker MG, Lennon DR. New Zealand epidemic of meningococcal disease identified by a strain with phenotype B: 4: P1.4. J Infect Dis 1998; 177: 497-500.